(Q39354410)

11 September 2017

Desloratadine 5 mg once daily improves the quality of life of patients with chronic idiopathic urticaria (English)

1 reference

11 September 2017

1 reference

1 reference

J M Lachapelle

1

1 reference

11 September 2017

J Decroix

2

1 reference

11 September 2017

A Henrijean

3

1 reference

11 September 2017

P P Roquet-Gravy

4

1 reference

11 September 2017

A De Swerdt

5

1 reference

11 September 2017

H Boonen

6

1 reference

11 September 2017

M Lecuyer

7

1 reference

11 September 2017

E Suys

8

1 reference

11 September 2017

G Speelman

9

1 reference

11 September 2017

N Vastesaeger

10

1 reference

11 September 2017

1 March 2006

1 reference

Journal of the European Academy of Dermatology and Venereology

11 September 2017

1 reference

11 September 2017

20

1 reference

11 September 2017

3

1 reference

11 September 2017

288-292

1 reference

The impact of chronic urticaria on the quality of life.

11 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01429.X

The extent and nature of disability in different urticarial conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01429.X

Treatment of urticaria. An evidence-based evaluation of antihistamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01429.X

Definition, classification, and routine diagnosis of urticaria: a consensus report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01429.X

Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01429.X

Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01429.X

Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01429.X

Desloratadine: A new, nonsedating, oral antihistamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01429.X

Clinical characteristics of pruritus in chronic idiopathic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01429.X

10.1111/J.1468-3083.2006.01429.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference